Skip to main content
Clinical Trials/ACTRN12618000431224
ACTRN12618000431224
Recruiting
未知

Transcriptome-wide alterations in gene expression of the glenohumeral joint capsule in people undergoing arthroscopic surgery for adhesive capsulitis, rotator cuff tears and osteoarthritis compared to people with non-inflammatory shoulder instability

Barwon Health0 sites100 target enrollmentMarch 26, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Adhesive capsulitis
Sponsor
Barwon Health
Enrollment
100
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 26, 2018
End Date
TBD
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Inclusion Criteria (AC and control):
  • Adults 18 – 70 yrs
  • Symptoms \> 3mths
  • oMRI – exclusion of degenerative or inflammatory arthropathy, as well as stage full thickness rotator cuff tears
  • Instability \> 1 episode for controls, pain only a minor feature
  • AC – Global loss of motion \> 30%
  • Inclusion criteria (rotator cuff tear)
  • 18 to 70 years of age
  • Symptoms \> 6 months (chronic tear)
  • Full thickness rotator cuff tear on MRI

Exclusion Criteria

  • Exclusion Criteria (AC and control):
  • Post surgical restricted motion
  • Instability episode \< 8wks prior – for control group
  • Imaging – MRI features – not fulfilling criteria
  • Exclusion criteria (rotator cuff tear)
  • Isolated subscapularis tears
  • Reduced motion (\<50% range) affecting daily living with clinical features of adhesive
  • Massive tears (\> 2 tendons)
  • Prior shoulder surgery in the affected shoulder
  • Intra\-articular or intra\-bursal corticosteroid injection within the preceding three months.

Outcomes

Primary Outcomes

Not specified

Similar Trials